| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.2M | -11.1% |
| SG&A Expense | $7.1M | -10.5% |
| Operating Income | -$14.2M | +10.8% |
| Pre-tax Income | -$13.9M | +10.3% |
| Net Income | -$13.9M | +12.9% |
| EPS (Basic) | -$0.42 | +0.0% |
| EPS (Diluted) | -$0.42 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.9M | -57.6% |
| Current Assets | $7.4M | -55.9% |
| Total Assets | $16.1M | -38.5% |
| Current Liabilities | $1.1M | -57.5% |
| Total Liabilities | $1.3M | -52.8% |
| Stockholders' Equity | $14.8M | -36.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $34K | +0.0% |